← Back to Patent Explorer
US3764616A Expired / Lapsed US ⏱️ 0.0 years remaining

21-phosphate esters of 17{60 -acyloxy-21 hydroxy steroids of the pregnane series

Assignee: Glaxo Laboratories Ltd
•
Filing: 1969-10-14
•
Granted: 1973-10-09
•
Expires: 1989-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention is concerned with novel 21-phosphate esters of 17 Alpha -acyloxy-21-hydroxy steroids of the pregane series and with methods of preparing such compounds. The compounds are useful as topical anti-inflamatory agents.

Inventors

  • 👤 J Elks
  • 👤 P May
  • 👤 G Phillipps

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; A61K31/573; A61K9/00; A61K9/0012; A61K9/0014; A61K9/0043; A61K9/0046; A61K9/20; A61K9/2004; A61K9/2013; A61K9/2018; B; B23; B23D; B23D33/00; C; C07; C07J; C07J5/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 17 words
A compound as claimed in claim 1 in which the 16-methyl group is in the Beta -configuration.
Claim 2
Dependent Claim 12 words
A compound as claimed in claim 1 in which Y represents fluorine.
Claim 3
Dependent Claim 25 words
A compound as claimed in claim 1 in which R1 represents an alkanoyl group selected from the group consisting of butyryl, isobutyryl, valeryl and isovaleryl.
Claim 4
Dependent Claim 56 words
A compound as claimed in claim 1 selected from the group consisting of betamethasone 17-isobutyrate 21-dihydrogen phosphate; betamethasone 17-valerate 21-dihydrogen phosphate; 9 Alpha -chloro- 16 Beta -methylprednisolone 17-isobutyrate 21-dihydrogen phosphate; dexamethasone 17-isobutyrate 21-dihydrogen phosphate; betamethasone 17-acetate 21-dihydrogen phosphate; betamethasone 17-propionate 21-dihydrogen phosphate; betamethasone 17-butyrate 21-dihydrogen phosphate; betamethasone 17-benzoate 21-dihydrogen phosphate; and a non-toxic water-soluble salt thereof.
Claim 5
Dependent Claim 16 words
A compound as claimed in claim 1 in the form of its sodium or potassium salt.

References Cited (Backward Citations)

CA792233A Cited
US2789117A Cited
US2967179A Cited
FR1365253A Cited
US3064016A Cited
US3073816A Cited
US3099654A Cited
US3053834A Cited
US3312590A Cited
DE2022695A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-10-08 1977-04-09 1977-10-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-10-08 1981-04-09 1981-10-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-10-08 1985-04-09 1985-10-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag